Tackling antibiotic resistance when treating pneumonia
New research has identified positive steps toward a better understanding of antimicrobial resistance (AMR), specifically in hospital-acquired pneumonia (HAP).
Jan 18, 2024
0
34
Heterocyclic Compounds: News and Research on Carbapenems
MeSH tree: D03.633.100.300.124
New antibiotic zosurabalpin shows promise against drug-resistant bacteria: An expert explains
Researchers have identified an entirely new class of antibiotic that can kill bacteria that are resistant to most current drugs.
Jan 8, 2024
0
48
Continuous meropenem no benefit in critically ill patients with sepsis
For critically ill patients with sepsis, continuous administration of meropenem does not improve a composite outcome of mortality and emergence of pandrug- or extensively drug-resistant bacteria compared with intermittent ...
Jun 22, 2023
0
35
CDC warns of potentially fatal bacterial illness on US gulf coast
A potentially deadly germ has made its way to the U.S. Gulf Coast, health officials warned this week.
Jun 2, 2023
0
102
Novel antibiotic succeeds in trial against hospital-acquired pneumonia
A Rutgers researcher leading a trial found that the novel combination antibiotic sulbactam-durlobactam combats dangerous pneumonia at least as well as the best currently approved treatment.
May 16, 2023
0
50
Investigation raises questions over lack of 'substantial evidence' for FDA approved antibiotic
Drugs approved in the US require "substantial evidence" that they are effective. But an investigation by The BMJ into the recent approval of the antibiotic Recarbrio from Merck suggests that these standards are being bypassed.
May 15, 2023
0
81
First evidence drug resistant bacteria can travel from gut to lung, increasing infection risks
A new Oxford University study released during World Antimicrobial Awareness Week has significant findings on how antimicrobial resistance (AMR) arises and persists. The results, published today in Nature Communications, provide ...
Nov 22, 2022
0
103
Dietary supplementation may improve antibiotic-induced GVHD following stem cell transplants
Researchers at The University of Texas MD Anderson Cancer Center have identified a specific gut bacterium involved in the progression of graft-versus-host disease (GVHD) after antibiotic treatment of allogeneic hematopoietic ...
Sep 29, 2022
0
48
